Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
Author:
Affiliation:
1. Laboratory of Molecular Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda; Maryland; USA
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Reference42 articles.
1. Global cancer statistics in the year 2000;Parkin;Lancet Oncol,2001
2. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis;El-Serag;Gastroenterology,2007
3. Hepatocellular carcinoma;Llovet;Lancet Oncol,2003
4. Guideline on the use of new anticancer drugs for the treatment of hepatocellular carcinoma 2010 update;Kaneko;Hepatol Res,2012
5. The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits;Chiu;Cancer,2012
Cited by 190 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer;Cell Reports;2024-07
2. Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma;World Journal of Surgical Oncology;2024-06-07
3. Critical role of miR-21/exosomal miR-21 in autophagy pathway;Pathology - Research and Practice;2024-05
4. Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1);Journal of Hepatocellular Carcinoma;2024-05
5. Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights;Biomedicines;2024-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3